Breaking News, Financial News

Financial Report: Millennium

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Millennium  4Q Revenues: $181.2 million (+30%) 4Q Earnings: $41.0 million (earnings were $8.3 million in 4Q2006) FY Revenues: $527.5 million (+8%) FY Earnings: $14.9 million (loss of $44.0 million FY2006) Comments: U.S. sales of Velcade were $265.2 million, up 20% for the year, and royalties were $166.9 million, up 24% due to growth in Velcade sales outside of the U.S., which were more than $500 million. This growth led to achievement of a non-recurring $40 million milestone fro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters